Want to see IN:COHANCE full AI Analyst Report?
Suven Pharmaceuticals Ltd. (COHANCE) Revenue
Suven Pharmaceuticals Ltd. Revenue
Suven Pharmaceuticals Ltd. had a revenue of 4.22B in the quarter ending Jun 30, 2026, with -31.80%. This bring the company's revenue in the last twelve months to 21.41B, Decreased 5.60%. In the fiscal year ending Mar 31, 2026, Suven Pharmaceuticals Ltd. had annual revenue of 22.69B with 89.43% growth.
- Revenue (ttm)
- 21.41B
- Revenue Growth
- 41.24%
- P/S Ratio
- 7.50
- Revenue/Employee
- INR 19,015,507
- Employees
- 1,193
- Market Cap
- INR 170.05B
Revenue Chart
Suven Pharmaceuticals Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 22.69B | 10.71B | 89.43% |
| Mar 31, 2025 | 11.98B | 1.46B | 13.91% |
| Mar 31, 2024 | 10.51B | -2.89B | -21.56% |
| Mar 31, 2023 | 13.40B | 201.07M | 1.52% |
| Mar 31, 2022 | 13.20B | 3.11B | 30.75% |
| Mar 31, 2021 | 10.10B | 1.76B | 21.10% |
| Mar 31, 2020 | 8.34B | -730.13M | -8.05% |
| Mar 31, 2019 | 9.07B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:COHANCE | 21.41B |
| IN:GRANULES | 56.18B |
| IN:JUBLPHARMA | 86.08B |
| IN:LAURUSLABS | 72.70B |
| IN:NEULANDLAB | 23.72B |
| IN:SOLARA | 15.35B |